Preferential Expression of Programmed Death Ligand 1 Protein in Tumor-Associated Macrophages and Its Potential Role in Immunotherapy for Hepatocellular Carcinoma
Dong-Jun Park(Catholic University of Korea), Seung Kew Yoon(St. Mary's Hospital)
Cited by 38
Related Papers
EpCAM-high liver cancer stem cells resist natural killer cell–mediated cytotoxicity by upregulating CEACAM1
|Journal for ImmunoTherapy of Cancer|2020|116
Branched-Chain Amino Acids Ameliorate Fibrosis and Suppress Tumor Growth in a Rat Model of Hepatocellular Carcinoma with Liver Cirrhosis
|PLoS ONE|2013|47
Immune Responses Following Locoregional Treatment for Hepatocellular Carcinoma: Possible Roles of Adjuvant Immunotherapy
|Pharmaceutics|2021|42
Systems approach to characterize the metabolism of liver cancer stem cells expressing CD133
|Scientific Reports|2017|39